Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
[Cancer Research 59, 1015-1020, March 1, 1999]
© 1999 American Association for Cancer Research
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Haiman, C. A.
Right arrow Articles by Hunter, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Haiman, C. A.
Right arrow Articles by Hunter, D. J.
[Cancer Research 59, 1015-1020, March 1, 1999]
© 1999 American Association for Cancer Research

Epidemiology and Prevention

The Relationship between a Polymorphism in CYP17 with Plasma Hormone Levels and Breast Cancer1

Christopher A. Haiman2, Susan E. Hankinson, Donna Spiegelman, Graham A. Colditz, Walter C. Willett, Frank E. Speizer, Karl T. Kelsey and David J. Hunter

Departments of Epidemiology [C. A. H., S. E. H., D. S., G. A. C., W. C. W., D. J. H.], Nutrition [W. C. W.], Environmental Health [F. E. S., K. T. K.], Cancer Cell Biology [K. T. K.], and Biostatistics [D. S.], and Harvard Center for Cancer Prevention [K. T. K., D. J. H.], Harvard School of Public Health, and Channing Laboratory, Department of Medicine, Brigham and Women’s Hospital [S. E. H., G. A. C., W. C. W., F. E. S., K. T. K., D. J. H.], Harvard Medical School, Boston, Massachusetts 02115

The A2 allele of CYP17 has been associated with polycystic ovarian syndrome, elevated levels of certain steroid hormones in premenopausal women, and increased breast cancer risk. We prospectively assessed the association between the A2 allele of CYP17 and breast cancer risk in a case-control study nested within the Nurses’ Health Study cohort. We also evaluated associations between this CYP17 genotype and plasma steroid hormone levels among postmenopausal controls not using hormone replacement to assess the biological significance of this genetic variant. Women with the A2 allele were not at an increased risk of incident breast cancer [OR (odds ratio), 0.85; 95% CI (confidence interval), 0.65–1.12] or advanced breast cancer (OR, 0.84; 95% CI, 0.54–1.32). We did observe evidence that the inverse association of late age at menarche with breast cancer may be modified by the CYP17 A2 allele. The protective effect of later age at menarche was only observed among women without the A2 allele (A1/A1 genotype: for age at menarche >=13 versus <13; OR, 0.57; 95% CI, 0.36–0.90; A1/A2 and A2/A2 genotypes: OR, 1.05; 95% CI, 0.76–1.45; P for interaction = 0.07). Among controls, we found women with the A2/A2 genotype to have elevated levels of estrone (+14.3%, P = 0.01), estradiol (+13.8%, P = 0.08), testosterone (+8.6%, P = 0.34), androstenedione (+17.1%, P = 0.06), dehydroepiandrosterone (+14.4%, P = 0.02), and dehydroepiandrosterone sulfate (+7.2%, P = 0.26) compared with women with the A1/A1 genotype. These data suggest that the A2 allele of CYP17 modifies endogenous hormone levels, but is not a strong independent risk factor for breast cancer.




This article has been cited by other articles:


Home page
 CarcinogenesisHome page
Y. Chen, M. D. Gammon, S. L. Teitelbaum, J. A. Britton, M. B. Terry, S. Shantakumar, S. M. Eng, Q. Wang, I. Gurvich, A. I. Neugut, et al.
Estrogen-biosynthesis gene CYP17 and its interactions with reproductive, hormonal and lifestyle factors in breast cancer risk: results from the Long Island Breast Cancer Study Project
Carcinogenesis, April 1, 2008; 29(4): 766 - 771.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
P. T. Campbell, L. Edwards, J. R. McLaughlin, J. Green, H. B. Younghusband, and M. O. Woods
Cytochrome P450 17A1 and Catechol O-Methyltransferase Polymorphisms and Age at Lynch Syndrome Colon Cancer Onset in Newfoundland
Clin. Cancer Res., July 1, 2007; 13(13): 3783 - 3788.
[Abstract] [Full Text] [PDF]

Home page
 Mol Hum ReprodHome page
M. Henningson, U. Johansson, A. Borg, H. Olsson, and H. Jernstrom
CYP17 genotype is associated with short menstrual cycles, early oral contraceptive use and BRCA mutation status in young healthy women
Mol. Hum. Reprod., April 1, 2007; 13(4): 231 - 236.
[Abstract] [Full Text] [PDF]

Home page
 Am J EpidemiolHome page
S. H. Olson, E. V. Bandera, and I. Orlow
Variants in Estrogen Biosynthesis Genes, Sex Steroid Hormone Levels, and Endometrial Cancer: A HuGE Review
Am. J. Epidemiol., February 1, 2007; 165(3): 235 - 245.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
G. Jasienska, M. Kapiszewska, P. T. Ellison, M. Kalemba-Drozdz, I. Nenko, I. Thune, and A. Ziomkiewicz
CYP17 Genotypes Differ in Salivary 17-{beta} Estradiol Levels: A Study Based on Hormonal Profiles from Entire Menstrual Cycles.
Cancer Epidemiol. Biomarkers Prev., November 1, 2006; 15(11): 2131 - 2135.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
B. M. Nathan, C. A. Hodges, P. J. Supelak, L. C. Burrage, J. H. Nadeau, and M. R. Palmert
A Quantitative Trait Locus on Chromosome 6 Regulates the Onset of Puberty in Mice
Endocrinology, November 1, 2006; 147(11): 5132 - 5138.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
V. W. Setiawan, C. A. Haiman, F. Z. Stanczyk, L. Le Marchand, and B. E. Henderson
Racial/Ethnic differences in postmenopausal endogenous hormones: the multiethnic cohort study.
Cancer Epidemiol. Biomarkers Prev., October 1, 2006; 15(10): 1849 - 1855.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
R. Piller, E. Verla-Tebit, S. Wang-Gohrke, J. Linseisen, and J. Chang-Claude
CYP17 Genotype Modifies the Association between Lignan Supply and Premenopausal Breast Cancer Risk in Humans
J. Nutr., June 1, 2006; 136(6): 1596 - 1603.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
G. S. Huggins, J. Y.Y. Wong, S. E. Hankinson, and I. De Vivo
GATA5 Activation of the Progesterone Receptor Gene Promoter in Breast Cancer Cells Is Influenced by the +331G/A Polymorphism
Cancer Res., February 1, 2006; 66(3): 1384 - 1390.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
G. Lurie, G. Maskarinec, R. Kaaks, F. Z. Stanczyk, and L. Le Marchand
Association of Genetic Polymorphisms with Serum Estrogens Measured Multiple Times During a 2-Year Period in Premenopausal Women
Cancer Epidemiol. Biomarkers Prev., June 1, 2005; 14(6): 1521 - 1527.
[Abstract] [Full Text] [PDF]

Home page
 Mol Hum ReprodHome page
N. Xita, A. Tsatsoulis, I. Stavrou, and I. Georgiou
Association of SHBG gene polymorphism with menarche
Mol. Hum. Reprod., June 1, 2005; 11(6): 459 - 462.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
N. C. Onland-Moret, C. H. van Gils, M. Roest, D. E. Grobbee, and P. H.M. Peeters
Cyp17, Urinary Sex Steroid Levels and Breast Cancer Risk in Postmenopausal Women
Cancer Epidemiol. Biomarkers Prev., April 1, 2005; 14(4): 815 - 820.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
H. S. Kok, N. C. Onland-Moret, K. M. van Asselt, C. H. van Gils, Y. T. van der Schouw, D. E. Grobbee, and P. H.M. Peeters
No association of estrogen receptor {alpha} and cytochrome P450c17{alpha} polymorphisms with age at menopause in a Dutch cohort
Hum. Reprod., February 1, 2005; 20(2): 536 - 542.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
B. K. Dunn, D. L. Wickerham, and L. G. Ford
Prevention of Hormone-Related Cancers: Breast Cancer
J. Clin. Oncol., January 10, 2005; 23(2): 357 - 367.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
R. C. Travis, M. Churchman, S. A. Edwards, G. Smith, P. K. Verkasalo, C. R. Wolf, H. Wolf, and T. J. Key
No Association of Polymorphisms in CYP17, CYP19, and HSD17-B1 with Plasma Estradiol Concentrations in 1,090 British Women
Cancer Epidemiol. Biomarkers Prev., December 1, 2004; 13(12): 2282 - 2284.
[Full Text] [PDF]

Home page
 Am J EpidemiolHome page
L. Sharp, A. H. Cardy, S. C. Cotton, and J. Little
CYP17 Gene Polymorphisms: Prevalence and Associations with Hormone Levels and Related Factors. A HuGE Review
Am. J. Epidemiol., October 15, 2004; 160(8): 729 - 740.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
A. M. Dunning, M. Dowsett, C. S. Healey, L. Tee, R. N. Luben, E. Folkerd, K. L. Novik, L. Kelemen, S. Ogata, P. D. P. Pharoah, et al.
Polymorphisms Associated With Circulating Sex Hormone Levels in Postmenopausal Women
J Natl Cancer Inst, June 16, 2004; 96(12): 936 - 945.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
V. W. Setiawan, S. E. Hankinson, G. A. Colditz, D. J. Hunter, and I. De Vivo
HSD17B1 Gene Polymorphisms and Risk of Endometrial and Breast Cancer
Cancer Epidemiol. Biomarkers Prev., February 1, 2004; 13(2): 213 - 219.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
J. Han, S. E. Hankinson, H. Ranu, I. De Vivo, and D. J. Hunter
Polymorphisms in DNA double-strand break repair genes and breast cancer risk in the Nurses' Health Study
Carcinogenesis, February 1, 2004; 25(2): 189 - 195.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
S. S. Tworoger, J. Chubak, E. J. Aiello, C. M. Ulrich, C. Atkinson, J. D. Potter, Y. Yasui, P. L. Stapleton, J. W. Lampe, F. M. Farin, et al.
Association of CYP17, CYP19, CYP1B1, and COMT Polymorphisms with Serum and Urinary Sex Hormone Concentrations in Postmenopausal Women
Cancer Epidemiol. Biomarkers Prev., January 1, 2004; 13(1): 94 - 101.
[Abstract] [Full Text] [PDF]

Home page
 Mol Hum ReprodHome page
H. Yamada, F. Sata, E. H. Kato, Y. Saijo, S. Kataoka, M. Morikawa, S. Shimada, T. Yamada, R. Kishi, and H. Minakami
A polymorphism in the CYP17 gene and intrauterine fetal growth restriction
Mol. Hum. Reprod., January 1, 2004; 10(1): 49 - 53.
[Abstract] [Full Text] [PDF]

Home page
 Mol Hum ReprodHome page
F. Sata, H. Yamada, A. Yamada, E. H. Kato, S. Kataoka, Y. Saijo, T. Kondo, J. Tamaki, H. Minakami, and R. Kishi
A polymorphism in the CYP17 gene relates to the risk of recurrent pregnancy loss
Mol. Hum. Reprod., November 1, 2003; 9(11): 725 - 728.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
I. De Vivo, S. E. Hankinson, G. A. Colditz, and D. J. Hunter
A Functional Polymorphism in the Progesterone Receptor Gene Is Associated with an Increase in Breast Cancer Risk
Cancer Res., September 1, 2003; 63(17): 5236 - 5238.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
H. Ahsan and A. G. Rundle
Measures of genotype versus gene products: promise and pitfalls in cancer prevention
Carcinogenesis, September 1, 2003; 24(9): 1429 - 1434.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
C. Ntais, A. Polycarpou, and J. P. A. Ioannidis
Association of the CYP17 Gene Polymorphism with the Risk of Prostate Cancer: A Meta-Analysis
Cancer Epidemiol. Biomarkers Prev., February 1, 2003; 12(2): 120 - 126.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
I. Gorai, K. Tanaka, M. Inada, H. Morinaga, Y. Uchiyama, R. Kikuchi, O. Chaki, and F. Hirahara
Estrogen-Metabolizing Gene Polymorphisms, But Not Estrogen Receptor-{alpha} Gene Polymorphisms, Are Associated with the Onset of Menarche in Healthy Postmenopausal Japanese Women
J. Clin. Endocrinol. Metab., February 1, 2003; 88(2): 799 - 803.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
S. E. McCann, K. B. Moysich, J. L. Freudenheim, C. B. Ambrosone, and P. G. Shields
The Risk of Breast Cancer Associated with Dietary Lignans Differs by CYP17 Genotype in Women
J. Nutr., October 1, 2002; 132(10): 3036 - 3041.
[Abstract] [Full Text] [PDF]

Home page
 MutagenesisHome page
H. S. Feigelson, R. McKean-Cowdin, and B. E. Henderson
Concerning the CYP17 MspA1 polymorphism and breast cancer risk: a meta-analysis
Mutagenesis, September 1, 2002; 17(5): 445 - 446.
[Full Text] [PDF]

Home page
 Cancer Res.Home page
E. I. O. Garner, E. E. Stokes, R. S. Berkowitz, S. C. Mok, and D. W. Cramer
Polymorphisms of the Estrogen-metabolizing Genes CYP17 and Catechol-O-methyltransferase and Risk of Epithelial Ovarian Cancer
Cancer Res., June 1, 2002; 62(11): 3058 - 3062.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
I. De Vivo, S. E. Hankinson, L. Li, G. A. Colditz, and D. J. Hunter
Association of CYP1B1 Polymorphisms and Breast Cancer Risk
Cancer Epidemiol. Biomarkers Prev., May 1, 2002; 11(5): 489 - 492.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
N. Kado, J. Kitawaki, H. Obayashi, H. Ishihara, H. Koshiba, I. Kusuki, K. Tsukamoto, G. Hasegawa, N. Nakamura, T. Yoshikawa, et al.
Association of the CYP17 gene and CYP19 gene polymorphisms with risk of endometriosis in Japanese women
Hum. Reprod., April 1, 2002; 17(4): 897 - 902.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
I. Stavrou, C. Zois, J.P.A. Ioannidis, and A. Tsatsoulis
Association of polymorphisms of the oestrogen receptor{alpha} gene with the age of menarche
Hum. Reprod., April 1, 2002; 17(4): 1101 - 1105.
[Abstract] [Full Text] [PDF]

Home page
 J. Med. Genet.Home page
M M de Jong, I M Nolte, G J te Meerman, W T A van der Graaf, J C Oosterwijk, J H Kleibeuker, M Schaapveld, and E G E de Vries
Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibility
J. Med. Genet., April 1, 2002; 39(4): 225 - 242.
[Abstract] [Full Text] [PDF]

Home page
 MutagenesisHome page
Z. Ye and J. M. Parry
The CYP17 MspA1 polymorphism and breast cancer risk: a meta-analysis
Mutagenesis, March 1, 2002; 17(2): 119 - 126.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
M.-W. Yu, Y.-C. Yang, S.-Y. Yang, S.-W. Cheng, Y.-F. Liaw, S.-M. Lin, and C.-J. Chen
Hormonal Markers and Hepatitis B Virus-Related Hepatocellular Carcinoma Risk: a Nested Case-Control Study Among Men
J Natl Cancer Inst, November 7, 2001; 93(21): 1644 - 1651.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
C. A. Haiman, M. J. Stampfer, E. Giovannucci, J. Ma, N. E. Decalo, P. W. Kantoff, and D. J. Hunter
The Relationship between a Polymorphism in CYP17 with Plasma Hormone Levels and Prostate Cancer
Cancer Epidemiol. Biomarkers Prev., July 1, 2001; 10(7): 743 - 748.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
K. Armstrong
Genetic Susceptibility to Breast Cancer: From the Roll of the Dice to the Hand Women Were Dealt
JAMA, June 13, 2001; 285(22): 2907 - 2909.
[Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
C. Guillemette, I. De Vivo, S. E. Hankinson, C. A. Haiman, D. Spiegelman, D. E. Housman, and D. J. Hunter
Association of Genetic Polymorphisms in UGT1A1 with Breast Cancer and Plasma Hormone Levels
Cancer Epidemiol. Biomarkers Prev., June 1, 2001; 10(6): 711 - 714.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
M. T. Goodman, K. McDuffie, C. Guo, K. Terada, and T. A. Donlon
CYP17 Genotype and Ovarian Cancer: A Null Case-Control Study
Cancer Epidemiol. Biomarkers Prev., May 1, 2001; 10(5): 563 - 564.
[Full Text]

Home page
 Cancer Res.Home page
C. A. Haiman, S. E. Hankinson, G. A. Colditz, D. J. Hunter, and I. De Vivo
A Polymorphism in CYP17 and Endometrial Cancer Risk
Cancer Res., May 1, 2001; 61(10): 3955 - 3960.
[Abstract] [Full Text]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
N. E. Allen, M. S. Forrest, and T. J. Key
The Association between Polymorphisms in the CYP17 and 5{{alpha}}-Reductase (SRD5A2) Genes and Serum Androgen Concentrations in Men
Cancer Epidemiol. Biomarkers Prev., March 1, 2001; 10(3): 185 - 189.
[Abstract] [Full Text]

Home page
 NEJMHome page
L. M. Hines, M. J. Stampfer, J. Ma, J. M. Gaziano, P. M. Ridker, S. E. Hankinson, F. Sacks, E. B. Rimm, and D. J. Hunter
Genetic Variation in Alcohol Dehydrogenase and the Beneficial Effect of Moderate Alcohol Consumption on Myocardial Infarction
N. Engl. J. Med., February 22, 2001; 344(8): 549 - 555.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
R. McKean-Cowdin, H. S. Feigelson, M. C. Pike, G. A. Coetzee, L. N. Kolonel, and B. E. Henderson
Risk of Endometrial Cancer and Estrogen Replacement Therapy History by CYP17 Genotype
Cancer Res., February 1, 2001; 61(3): 848 - 849.
[Abstract] [Full Text]

Home page
 NEJMHome page
M. Clemons and P. Goss
Estrogen and the Risk of Breast Cancer
N. Engl. J. Med., January 25, 2001; 344(4): 276 - 285.
[Full Text] [PDF]

Home page
 Cancer Res.Home page
H. S. Feigelson, R. McKean-Cowdin, G. A. Coetzee, D. O. Stram, L. N. Kolonel, and B. E. Henderson
Building a Multigenic Model of Breast Cancer Susceptibility: CYP17 and HSD17B1 Are Two Important Candidates
Cancer Res., January 1, 2001; 61(2): 785 - 789.
[Abstract] [Full Text]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
K. Mitrunen, N. Jourenkova, V. Kataja, M. Eskelinen, V.-M. Kosma, S. Benhamou, H. Vainio, M. Uusitupa, and A. Hirvonen
Steroid Metabolism Gene CYP17 Polymorphism and the Development of Breast Cancer
Cancer Epidemiol. Biomarkers Prev., December 1, 2000; 9(12): 1343 - 1348.
[Abstract] [Full Text]

Home page
 JNCI J Natl Cancer InstHome page
A. B. Spurdle, J. L. Hopper, G. S. Dite, X. Chen, J. Cui, M. R. E. McCredie, G. G. Giles, M. C. Southey, D. J. Venter, D. F. Easton, et al.
CYP17 Promoter Polymorphism and Breast Cancer in Australian Women Under Age Forty Years
J Natl Cancer Inst, October 18, 2000; 92(20): 1674 - 1681.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
T. Habuchi, Z. Liqing, T. Suzuki, R. Sasaki, N. Tsuchiya, H. Tachiki, N. Shimoda, S. Satoh, K. Sato, Y. Kakehi, et al.
Increased Risk of Prostate Cancer and Benign Prostatic Hyperplasia Associated with a CYP17 Gene Polymorphism with a Gene Dosage Effect
Cancer Res., October 1, 2000; 60(20): 5710 - 5713.
[Abstract] [Full Text]

Home page
 J Natl Cancer Inst MonogrHome page
M. C. Bosland
Chapter 2: The Role of Steroid Hormones in Prostate Carcinogenesis
J Natl Cancer Inst Monographs, July 1, 2000; 2000(27): 39 - 66.
[Abstract] [Full Text] [PDF]

Home page
 J Natl Cancer Inst MonogrHome page
P. A. Thompson and C. Ambrosone
Chapter 7: Molecular Epidemiology of Genetic Polymorphisms in Estrogen Metabolizing Enzymes in Human Breast Cancer
J Natl Cancer Inst Monographs, July 1, 2000; 2000(27): 125 - 134.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
B. E. Henderson and H. S. Feigelson
Hormonal carcinogenesis
Carcinogenesis, March 1, 2000; 21(3): 427 - 433.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
C. Guillemette, R. C. Millikan, B. Newman, and D. E. Housman
Genetic Polymorphisms in Uridine Diphospho-Glucuronosyltransferase 1A1 and Association with Breast Cancer among African Americans
Cancer Res., February 1, 2000; 60(4): 950 - 956.
[Abstract] [Full Text]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
H. Bartsch, U. Nair, A. Risch, M. Rojas, H. Wikman, and K. Alexandrov
Genetic Polymorphism of CYP Genes, Alone or in Combination, as a Risk Modifier of Tobacco-related Cancers
Cancer Epidemiol. Biomarkers Prev., January 1, 2000; 9(1): 3 - 28.
[Abstract] [Full Text]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
S. S. Coughlin and M. Piper
Genetic Polymorphisms and Risk of Breast Cancer
Cancer Epidemiol. Biomarkers Prev., November 1, 1999; 8(11): 1023 - 1032.
[Full Text]

Home page
 Cancer Res.Home page
H. S. Feigelson, R. McKean-Cowdin, M. C. Pike, G. A. Coetzee, L. N. Kolonel, A. M. Y. Nomura, L. L. Marchand, and B. E. Henderson
Cytochrome P450c17{{alpha}} Gene (CYP17) Polymorphism Predicts Use of Hormone Replacement Therapy
Cancer Res., August 1, 1999; 59(16): 3908 - 3910.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1999 by the American Association for Cancer Research.